Parenterally administered kainic acid induces a persistent hyperalgesia in the mouse and rat

Pain

Volumn 83, Issue 2, 1999, Pages 347-358

  Giovengo, Susan L ^a   Kitto, Kelley F ^a   Kurtz, Harold J ^a   Velázquez, Rubén A ^a   Larson, Alice A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Dorsal root ganglia; Hyperalgesia; Kainic acid; Nociception; Primary afferent fibers; Spinal cord

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HOT PLATE TEST; HYPERALGESIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NERVE PROJECTION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; SPINAL CORD; SPINAL GANGLION; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HEAT; HINDLIMB; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; KAINIC ACID; MALE; MICE; MICE, INBRED STRAINS; PHYSICAL STIMULATION; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; TOUCH;

EID: 0032852569     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00118-9     Document Type: Article

References (60)

1. Aanonsen L.M., Wilcox G.L. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther. 243:1987;9-19.
2. Agrawal S.G., Evans R.H. The primary afferent depolarizing action of kainate in the rat. Br J Pharmacol. 87:1986;345-355.
3. 109Cd in the nervous system of rats after intravenous injection. Acta Neuropathol. 69:1986;111-116.
4. Ault B., Hildebrand L.M. Activation of nociceptive reflexes by peripheral kainate receptors. J Pharmacol Exp Ther. 265:1993;927-932.
5. Ault B., Hildebrand L.M. L-Glutamate activates peripheral nociceptors. Agents Actions. 39:1993;142-144.
6. Ben-Ari Y., Tremblay E., Riche D., Ghilini G., Naquet R. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline and pentetrazole: metabolic mapping using the decoxyglucose method with special reference to the pathology of epilepsy. Neuroscience. 6:1981;1361-1391.
7. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
8. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
9. Berger M.L., Lefauconnier J.M., Tremblay E., Ben-Ari Y. Limbic seizures induced by systemically applied kainic acid: how much kainic acid reaches the brain? Scharcz, E., Ben-Ari Y. Excitatory amino acids and epilepsy. 1986;109-209 Plenum, New York.
10. 3H] aspartic acid in cerebellar slices. Neurochem Res. 21:1996;1527-1533.
11. Brennan T.J., Vandermeuline E.P., Gebhart G.F. Characterization of a rat model of incisional pain. Pain. 64:1996;493-501.
12. Caldwell M.D., Mastrofrancesco B., Shearer J., Bereiter D. The temporal change in amino acid concentration within wound fluid - a putative rationale. Prog Clin Biol Res. 365:1991;205-222.
13. Carlton S.M., Hargett G.L., Coggeshall R.E. Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci Lett. 197:1995;25-28.
14. Coderre T.J., Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci. 12:1992;3665-3670.
15. De Biasi S., Rustioni A. Glutamate and substance P coexist in primary afferent terminals in superficial laminae of spinal cord. Proc Natl Acad Sci USA. 85:1988;7820-7824.
16. De Castro Costa M., Sutter P., Vybels J., van Hees J. Adjuvant-induced arthritis in rats: a possible animal model of chronic pain. Pain. 10:1981;173-185.
17. Dougherty P.M., Palecek J., Paleckova V., Sorkin L.S., Willis W.D. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J Neurosci. 12:1992;3025-3041.
18. Evans R.H., Evans S.J., Pook P.C., Sunter D.C. A comparison of excitatory amino acid antagonists acting at primary afferent C fibres and motoneurones of the isolated spinal cord of the rat. Br J Pharmacol. 91:1987;531-537.
19. Ferkany J.W., Zaczek R., Coyle J.T. Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature. 298:1982;757-759.
20. Field M.J., Holloman E.F., McCleary S., Hughes J., Singh L. Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther. 282:1997;1242-1246.
21. Gallo V., Suergiu R., Giovannini C., Levi G. Glutamate receptor subtypes in cultured cerebellar neurons: modulation of glutamate and gamma-aminobutyric acid release. J Neurochem. 49:1987;1801-1809.
22. Goettl V.M., Larson A.A. Antinociception induced by 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX. Brain Res. 642:1984;334-338.
23. Gregg R.W., Molepo J.M., Monpetit V.J.A., Mikael N.Z., Redmond D., Gadia M., Stewart D.J. Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol. 10:1992;795-803.
24. Huettner J.E. Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron. 5:1990;255-266.
25. Hylden J.L.K., Wilcox G. Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 67:1980;313-316.
26. Jackson D.L., Graff C.B., Richardson J.D., Hargreaves K.M. Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur J Pharmacol. 284:1995;321-325.
27. Kangrga I., Randic M. Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low- and high-threshold primary afferent fibers: modulation by μ-opioids. Brain Res. 553:1991;347-352.
28. Kim S.H., Chung J.M. An experimental model of peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
29. Krespan B., Berl S., Niklas W.J. Alteration in neuronal-glial metabolism of glutamate by the neurotoxin kainic acid. J Neurochem. 38:1982;509-518.
30. Larson A.A., Sun X. Modulation of kainic acid-induced activity in the mouse spinal cord by the amino terminus of substance P: sensitivity to opioid antagonists. J Pharmacol Exp Ther. 265:1993;159-165.
31. Larson A.A., Brown D.R., El-Atrash S., Walser M.M. Pain threshold changes in adjuvant-induced inflammation: a possible model of chronic pain in the mouse. Pharmacol Biochem Behav. 24:1986;49-53.
32. Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M., Porreca F., Wilcox G.L. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain. 72:1997;253-260.
33. Lewin G.R., Ritter A.M., Mendell L.M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci. 13:1993;2136-2148.
34. Lewin G.R., Rueff A., Mendell L.M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci. 6:1994;1903-1912.
35. Liu H., Wang H., Sheng M., Jan L.Y., Basbaum A.I. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci USA. 91:1994;8383-8387.
36. Löscher W., Nolting B., Honack D. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy: comparison with other NMDA antagonists, and with diazepam and phenobarbital. Eur J Pharmacol. 152:1988;9-17.
37. Lothman W., Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218:1981;299-318.
38. Malcangio M., Malmberg-Aiello P., Giotti A., Ghelardini C., Bartolini A. Desensitization of GABAB receptors and antagonism by CGP 35348, prevent bicuculline- and picrotoxin-induced antinociception. Neuropharmacology. 31:1992;783-791.
39. McMahon S.B., Lewin G.R., Wall P.D. Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol. 3:1993;602-610.
40. 3H-kainic acid after intraventricular injection. Life Sci. 26:1980;133-138.
41. Nakammura-Craig M., Rollenfant R.L. Effect of lamotrigine in the acute and shronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain. 63:1995;33-37.
42. Näsström J., Karlsson U., Post C. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur J Pharmacol. 212:1992;21-29.
43. Neugebauer V., Lucke T., Schaible H.G. Differential effects of N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists on the responses of rat spinal neurons with joint input. Neurosci Lett. 155:1993;29-32.
44. Olney J.W. Neurotoxicity of excitatory amino acids. McGeer E.G., Olney J.W., McGeer P.L. Kainic acid as a tool in neurobiology. 1978;95-121 Raven Press, New York.
45. Olney J.W. Excitatory transmitter neurotoxicity. Neurobiol Aging. 15:1994;259-260.
46. Raigorodsky G., Urca G. Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems. Brain Res. 422:1987;158-162.
47. Sahara Y., Noro N., Iida Y., Soma K., Nakamura Y. Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons. J Neurosci. 17:1997;6611-6620.
48. Sato K., Kiyama H., Park H.T., Tohyama M. AMPA, kainic acid and NMDA receptors are expressed in the rat DRG neurones. NeuroReport. 4:1993;1263-1265.
49. Schaible H.G., Grubb B.D. Afferent and spinal mechanisms of joint pain. Pain. 55:1993;5-54.
50. Schwob J.E., Fuller T., Price J.L., Olney J.W. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience. 5:1980;991-1014.
51. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
52. Skilling S.R., Smullin D.H., Beitz A.J., Larson A.A. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J Neurochem. 51:1988;127-132.
53. Sperk G. Kainic acid seizures in the rat. Prog Neurobiol. 42:1994;1-32.
54. Sugimoto T., Bennett G.J., Kajander K.C. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine. Pain. 42:1990;205-213.
55. Tölle T.R., Berthele A., Zieglgansberger W., Seeburg P.H., Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci. 13:1993;5009-5028.
56. Tracey D.J., Biasi S.D., Phend K., Rustioni A. Aspartate-like immunoreactivity in primary afferent neurons. Neuroscience. 40:1991;673-686.
57. Urca G., Urca R. Neurotoxic effects of excitatory amino acids in the mouse spinal cord: quisqualate and kainate, but not N-methyl-D-aspartate, induced permanent neural damage. Brain Res. 529:1990;7-15.
58. Velázquez R.A., Sun X., Kurtz H.J., Larson A.A. Possible role of the N-terminus of substance P in kainic acid-induced toxicity in rats. Brain Res. 624:1993;109-114.
59. Watkins J.C., Evans R.H. Excitatory amino acid transmitters. Ann Rev Pharmacol Toxicol. 21:1981;165-204.
60. Yang L.C., Marsala M., Yaksh T.L. Effect of spinal kainic acid receptor activation on spinal amino acid and prostaglandin E2 release in rat. Neuroscience. 75:1996;453-461.